Andrea Russo, EHRA 2018 – BRUISE CONTROL 1 and 2 Combined Analysis
Andrea Russo (Cooper University Health Care, New Jersey, US) discusses the background and rationale behind the BRUISE CONTROL 1 and 2 studies. BRUISE CONTROL 1 looked at patients receiving warfarin and compared randomised patients to uninterrupted anticoagulation with warfarin versus bridging with heparin. BRUISE CONTROL 2 then compared uninterrupted direct oral anticoagulant therapy to holding the drug for at least 24 hours prior to the procedure. The data from the two studies lead to an investigation into other factors that present bleeding risk, including antiplatelet agents. Dr Russo discusses the background and rational of the BRUISE CONTROL 1 and 2 studies, the results of the combined analysis presented at EHRA 2018 and the next steps in this area of research over coming years.
Filmed at EHRA 2018, Barcelona.
View more content here.
1. What was the background and rationale behind the BRUISE CONTROL 1 and 2 studies? 0:09
2. What are your highlights from this year’s meeting? 2:33
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.
Share this Video
Related Videos In Arrhythmia
World Heart Rhythm Week: Considerations and challenges in arrhythmia
It’s World Heart Rhythm Week 2023! Learn about key considerations for managing and treating arrhythmias, ongoing research and the importance of seeking medical advice for syncope.
Andrew Krahn: Heart Rhythm 2023 & HRX 2023 – The latest Innovations in arrhythmia care and technology
Dr Andrew Krahn, President, Heart Rhythm Society (HRS), discusses the upcoming Heart Rhythm 2023 meeting (May 19-21, 2023, New Orleans, LA, USA), and the HRX 2023 conference (September 21-23, 2023, in Seattle, WA, USA) hosted by the Heart Rhythm Society (HRS), a non-profit organization dedicated to improving the care of patients with heart rhythm disorders […]
Andrew Krahn: Heart Rhythm Society Update
Dr Andrew Krahn, President, Heart Rhythm Society (HRS), presents the HRS aims and goals for the coming year, and their dedication to improving the care of patients with heart rhythm disorders through innovation, education, research, and advocacy. Dr Krahn also highlights the member benefits of joining HRS, which include access to the latest research and […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!